Natural killer cells/therapy

UH Seidman Cancer Center to Launch First-Ever Trial of NK Therapy and Vactosertib in Treating Colorectal Cancer and Hematological Malignancies

Trial employs new method of expanding and activating universal donor NK cells developed in Cleveland - Innovations in Cancer | Winter 2022

2/14/2022 By UH